Total
0
Shares
Medibio (ASX:MEB) - Managing Director, Claude Solitario - The Market Herald
Managing Director, Claude Solitario
Source: Cyber Clinic
  • Mental health tech company Medibio (MEB) has been granted a patent by the U.S. Patent and Trademark Office
  • The patent is titled 'Method and System for Monitoring Stress Conditions' and relates machine learning that monitors stress conditions by analysing heart rate data collected before, during and after sleep
  • This patent will be instrumental in protecting Medibio's mental well-being program, ilumen, and its consumer app, which is currently under development
  • Medibio is now in the process of reviewing the scope of existing patents and will advise the market of any findings
  • Company shares are steady on the market this morning and are trading for 1.2 cents each

Mental health tech company Medibio (MEB) has been granted a patent by the U.S. Patent and Trademark Office.

The patent is titled 'Method and System for Monitoring Stress Conditions' and relates machine learning that monitors stress conditions by analysing heart rate data collected before, during and after sleep.

This patent will be instrumental in protecting Medibio's mental well-being program, ilumen, and its consumer app, which currently under development.

ilumen is a program which provides data feedback to help employees improve their mental well-being.

It assesses the user's wellness by conducting surveys which track much sleep they are getting, their exercise patterns and work hours. The user will receive their results with recommendations on coping strategies and a personal development plan.

Medibio is now in the process of reviewing the scope of existing patents and will advise the market of any findings.

Company shares are steady on the market and are trading for 1.2 cents each at 11:19 am AEST.


Subscribe


MEB by the numbers
More From The Market Herald
Praemium (ASX:PPS) - CEO, Michael Ohanessian - The Market Herald

" Praemium (ASX:PPS) to purchase remaining shares in Powerwrap (ASX:PWL)

Investment manager Praemium (PPS) will move to compulsorily purchase the remaining shares in Powerwrap (PWL).
iCandy Interactive (ASX:ICI) - Chief Operating Officer, Desmond Lee (left) - The Market Herald

" iCandy Interactive (ASX:ICI) completes game trial with Google Play, as pre-orders soar

iCandy Interactive’s (ICI) game, Masketeers: Idle Has Fallen, has completed its early access trial in collaboration with Google Play.
Suda Pharmaceuticals (ASX:SUD) - CEO, Dr Michael Baker - The Market Herald

" Suda Pharmaceuticals’ (ASX:SUD) canine trial supports alternative delivery of anagrelide

Suda Pharmaceuticals (SUD) has received the final results from a canine trial of various oral formulations of anagrelide.
icetana (ASX:ICE) - Managing Director & CEO, Matt Macfarlane - The Market Herald

" icetana’s (ASX:ICE) motion intelligence platform deployed at two U.S. prisons

Video analytics solutions provider icetana (ICE) has secured two orders for its motion intelligence platform from hardware vendor, Rasillient Systems.